APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-D Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-D Immunoglobulin Industry Growth and Trends Forecast to 2032

22 December 202590 pages

Choose your research edition.

Industry ResearchAnti-D Immunoglobulin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-D Immunoglobulin Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Anti-D Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-D Immunoglobulin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-D Immunoglobulin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Anti-D Immunoglobulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-D Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-D Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-D Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-D Immunoglobulin include Grifols, Bayer, Saol Therapeutics, Octapharma, Kedrion Biopharma and Bio Products Laboratory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-D Immunoglobulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-D Immunoglobulin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-D Immunoglobulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-D Immunoglobulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-D Immunoglobulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-D Immunoglobulin Market by Company

Grifols

Bayer

Saol Therapeutics

Octapharma

Kedrion Biopharma

Bio Products Laboratory

Anti-D Immunoglobulin Segment by Type

Vial

Prefilled Syringes

Anti-D Immunoglobulin Segment by Application

Hospital

Clinic

Anti-D Immunoglobulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-D Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-D Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-D Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-D Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-D Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vial Table 2. Major Company of Prefilled Syringes Table 3. Global Anti-D Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Anti-D Immunoglobulin Sales by Type (2021-2026) & (k units) Table 5. Global Anti-D Immunoglobulin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Anti-D Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Anti-D Immunoglobulin Sales Market Share in Value by Type (2021-2026) Table 8. Global Anti-D Immunoglobulin Price by Type (2021-2026) & (US$/unit) Table 9. Global Anti-D Immunoglobulin Sales by Type (2027-2032) & (k units) Table 10. Global Anti-D Immunoglobulin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Anti-D Immunoglobulin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Anti-D Immunoglobulin Sales Market Share in Value by Type (2027-2032) Table 13. Global Anti-D Immunoglobulin Price by Type (2027-2032) & (US$/unit) Table 14. North America Anti-D Immunoglobulin Sales by Type (2021-2026) & (k units) Table 15. North America Anti-D Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Anti-D Immunoglobulin Sales by Type (2021-2026) & (k units) Table 17. Europe Anti-D Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Anti-D Immunoglobulin Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Anti-D Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Anti-D Immunoglobulin Sales by Type (2021-2026) & (k units) Table 21. Latin America Anti-D Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Anti-D Immunoglobulin Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Anti-D Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 24. Anti-D Immunoglobulin Industry Trends Table 25. Anti-D Immunoglobulin Industry Drivers Table 26. Anti-D Immunoglobulin Industry Opportunities and Challenges Table 27. Anti-D Immunoglobulin Industry Restraints Table 28. Global Anti-D Immunoglobulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Anti-D Immunoglobulin Revenue Market Share by Company (2021-2026) Table 30. Global Anti-D Immunoglobulin Sales by Company (2021-2026) & (k units) Table 31. Global Anti-D Immunoglobulin Sales Share by Company (2021-2026) Table 32. Global Anti-D Immunoglobulin Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Anti-D Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anti-D Immunoglobulin Major Company Production Sites and Headquarters Table 35. Global Anti-D Immunoglobulin Company, Product Type & Application Table 36. Global Anti-D Immunoglobulin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Anti-D Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anti-D Immunoglobulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Anti-D Immunoglobulin Sales by Region (2021-2026) & (k units) Table 41. Global Anti-D Immunoglobulin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Anti-D Immunoglobulin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Anti-D Immunoglobulin Sales Market Share in Value by Region (2021-2026) Table 44. Global Anti-D Immunoglobulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Anti-D Immunoglobulin Sales by Region (2027-2032) & (k units) Table 46. Global Anti-D Immunoglobulin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Anti-D Immunoglobulin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Anti-D Immunoglobulin Sales Market Share in Value by Region (2027-2032) Table 49. Global Anti-D Immunoglobulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Anti-D Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Anti-D Immunoglobulin Sales by Application (2021-2026) & (k units) Table 52. Global Anti-D Immunoglobulin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Anti-D Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Anti-D Immunoglobulin Sales Market Share in Value by Application (2021-2026) Table 55. Global Anti-D Immunoglobulin Price by Application (2021-2026) & (US$/unit) Table 56. Global Anti-D Immunoglobulin Sales by Application (2027-2032) & (k units) Table 57. Global Anti-D Immunoglobulin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Anti-D Immunoglobulin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Anti-D Immunoglobulin Sales Market Share in Value by Application (2027-2032) Table 60. Global Anti-D Immunoglobulin Price by Application (2027-2032) & (US$/unit) Table 61. North America Anti-D Immunoglobulin Sales by Application (2021-2026) & (k units) Table 62. North America Anti-D Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Anti-D Immunoglobulin Sales by Application (2021-2026) & (k units) Table 64. Europe Anti-D Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Anti-D Immunoglobulin Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Anti-D Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Anti-D Immunoglobulin Sales by Application (2021-2026) & (k units) Table 68. Latin America Anti-D Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Anti-D Immunoglobulin Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Anti-D Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 71. Grifols Company Information Table 72. Grifols Business Overview Table 73. Grifols Anti-D Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Grifols Anti-D Immunoglobulin Product Portfolio Table 75. Grifols Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Anti-D Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Bayer Anti-D Immunoglobulin Product Portfolio Table 80. Bayer Recent Development Table 81. Saol Therapeutics Company Information Table 82. Saol Therapeutics Business Overview Table 83. Saol Therapeutics Anti-D Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Saol Therapeutics Anti-D Immunoglobulin Product Portfolio Table 85. Saol Therapeutics Recent Development Table 86. Octapharma Company Information Table 87. Octapharma Business Overview Table 88. Octapharma Anti-D Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Octapharma Anti-D Immunoglobulin Product Portfolio Table 90. Octapharma Recent Development Table 91. Kedrion Biopharma Company Information Table 92. Kedrion Biopharma Business Overview Table 93. Kedrion Biopharma Anti-D Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Kedrion Biopharma Anti-D Immunoglobulin Product Portfolio Table 95. Kedrion Biopharma Recent Development Table 96. Bio Products Laboratory Company Information Table 97. Bio Products Laboratory Business Overview Table 98. Bio Products Laboratory Anti-D Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Bio Products Laboratory Anti-D Immunoglobulin Product Portfolio Table 100. Bio Products Laboratory Recent Development Table 101. North America Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. North America Anti-D Immunoglobulin Sales by Country (2021-2026) & (k units) Table 103. North America Anti-D Immunoglobulin Sales Market Share by Country (2021-2026) Table 104. North America Anti-D Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 105. North America Anti-D Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 106. North America Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Anti-D Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Anti-D Immunoglobulin Market Share by Country (2021-2026) Table 109. North America Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Anti-D Immunoglobulin Market Share Forecast by Country (2027-2032) Table 111. Europe Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Europe Anti-D Immunoglobulin Sales by Country (2021-2026) & (k units) Table 113. Europe Anti-D Immunoglobulin Sales Market Share by Country (2021-2026) Table 114. Europe Anti-D Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 115. Europe Anti-D Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Anti-D Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Anti-D Immunoglobulin Market Share by Country (2021-2026) Table 119. Europe Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Anti-D Immunoglobulin Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Anti-D Immunoglobulin Sales by Country (2021-2026) & (k units) Table 123. Asia-Pacific Anti-D Immunoglobulin Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Anti-D Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 125. Asia-Pacific Anti-D Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Anti-D Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Anti-D Immunoglobulin Market Share by Country (2021-2026) Table 129. Asia-Pacific Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Anti-D Immunoglobulin Market Share Forecast by Country (2027-2032) Table 131. Latin America Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Latin America Anti-D Immunoglobulin Sales by Country (2021-2026) & (k units) Table 133. Latin America Anti-D Immunoglobulin Sales Market Share by Country (2021-2026) Table 134. Latin America Anti-D Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 135. Latin America Anti-D Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Anti-D Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Anti-D Immunoglobulin Market Share by Country (2021-2026) Table 139. Latin America Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Anti-D Immunoglobulin Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Anti-D Immunoglobulin Sales by Country (2021-2026) & (k units) Table 143. Middle East and Africa Anti-D Immunoglobulin Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Anti-D Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 145. Middle East and Africa Anti-D Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Anti-D Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Anti-D Immunoglobulin Market Share by Country (2021-2026) Table 149. Middle East and Africa Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Anti-D Immunoglobulin Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Anti-D Immunoglobulin Distributors List Table 154. Anti-D Immunoglobulin Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Anti-D Immunoglobulin Image Figure 2. Global Anti-D Immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-D Immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-D Immunoglobulin Sales (2021-2032) & (k units) Figure 5. Vial Image Figure 6. Global Vial Sales YoY Growth (2021-2032) & (k units) Figure 7. Prefilled Syringes Image Figure 8. Global Prefilled Syringes Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Anti-D Immunoglobulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Anti-D Immunoglobulin Market Share by Type 2025 VS 2032 Figure 11. North America Anti-D Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 12. North America Anti-D Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 13. Europe Anti-D Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Anti-D Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Anti-D Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Anti-D Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Anti-D Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Anti-D Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Anti-D Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Anti-D Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Anti-D Immunoglobulin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Anti-D Immunoglobulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Anti-D Immunoglobulin Market Share by Application 2025 VS 2032 Figure 29. North America Anti-D Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 30. North America Anti-D Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 31. Europe Anti-D Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Anti-D Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Anti-D Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Anti-D Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Anti-D Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Anti-D Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Anti-D Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Anti-D Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 39. North America Anti-D Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Anti-D Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Anti-D Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Anti-D Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Anti-D Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Anti-D Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anti-D Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Anti-D Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Anti-D Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Anti-D Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Anti-D Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Anti-D Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Anti-D Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Anti-D Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Anti-D Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Anti-D Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Anti-D Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Anti-D Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Anti-D Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Anti-D Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Anti-D Immunoglobulin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Anti-D Immunoglobulin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Vial
  • Prefilled Syringes
Applications
  • Hospital
  • Clinic
Companies covered
  • Grifols
  • Bayer
  • Saol Therapeutics
  • Octapharma
  • Kedrion Biopharma
  • Bio Products Laboratory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-D Immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-D Immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-D Immunoglobulin Market by Type
  6. 1.3.1 Vial
  7. 1.3.2 Prefilled Syringes
  8. 1.4 Global Anti-D Immunoglobulin Market Size by Type
  9. 1.4.1 Global Anti-D Immunoglobulin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Anti-D Immunoglobulin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Anti-D Immunoglobulin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Anti-D Immunoglobulin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Anti-D Immunoglobulin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Anti-D Immunoglobulin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Anti-D Immunoglobulin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Anti-D Immunoglobulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-D Immunoglobulin Industry Trends
  2. 2.2 Anti-D Immunoglobulin Industry Drivers
  3. 2.3 Anti-D Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Anti-D Immunoglobulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-D Immunoglobulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-D Immunoglobulin Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-D Immunoglobulin Price (2021-2026)
  4. 3.4 Global Anti-D Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-D Immunoglobulin Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-D Immunoglobulin Company, Product Type & Application
  7. 3.7 Global Anti-D Immunoglobulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-D Immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-D Immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-D Immunoglobulin Tier 1, Tier 2, and Tier 3
4 Anti-D Immunoglobulin Regional Status and Outlook
  1. 4.1 Global Anti-D Immunoglobulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-D Immunoglobulin Historic Market Size by Region
  3. 4.2.1 Global Anti-D Immunoglobulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-D Immunoglobulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-D Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-D Immunoglobulin Forecasted Market Size by Region
  7. 4.3.1 Global Anti-D Immunoglobulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-D Immunoglobulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-D Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-D Immunoglobulin by Application
  1. 5.1 Anti-D Immunoglobulin Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Anti-D Immunoglobulin Market Size by Application
  5. 5.2.1 Global Anti-D Immunoglobulin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anti-D Immunoglobulin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anti-D Immunoglobulin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anti-D Immunoglobulin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anti-D Immunoglobulin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anti-D Immunoglobulin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anti-D Immunoglobulin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anti-D Immunoglobulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Grifols
  2. 6.1.1 Grifols Company Information
  3. 6.1.2 Grifols Business Overview
  4. 6.1.3 Grifols Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Grifols Anti-D Immunoglobulin Product Portfolio
  6. 6.1.5 Grifols Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Anti-D Immunoglobulin Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Saol Therapeutics
  14. 6.3.1 Saol Therapeutics Company Information
  15. 6.3.2 Saol Therapeutics Business Overview
  16. 6.3.3 Saol Therapeutics Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Saol Therapeutics Anti-D Immunoglobulin Product Portfolio
  18. 6.3.5 Saol Therapeutics Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Octapharma Anti-D Immunoglobulin Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 Kedrion Biopharma
  26. 6.5.1 Kedrion Biopharma Company Information
  27. 6.5.2 Kedrion Biopharma Business Overview
  28. 6.5.3 Kedrion Biopharma Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kedrion Biopharma Anti-D Immunoglobulin Product Portfolio
  30. 6.5.5 Kedrion Biopharma Recent Developments
  31. 6.6 Bio Products Laboratory
  32. 6.6.1 Bio Products Laboratory Company Information
  33. 6.6.2 Bio Products Laboratory Business Overview
  34. 6.6.3 Bio Products Laboratory Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bio Products Laboratory Anti-D Immunoglobulin Product Portfolio
  36. 6.6.5 Bio Products Laboratory Recent Developments
7 North America by Country
  1. 7.1 North America Anti-D Immunoglobulin Sales by Country
  2. 7.1.1 North America Anti-D Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-D Immunoglobulin Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-D Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-D Immunoglobulin Market Size by Country
  6. 7.2.1 North America Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-D Immunoglobulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-D Immunoglobulin Sales by Country
  2. 8.1.1 Europe Anti-D Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-D Immunoglobulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-D Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-D Immunoglobulin Market Size by Country
  6. 8.2.1 Europe Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-D Immunoglobulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-D Immunoglobulin Sales by Country
  2. 9.1.1 Asia-Pacific Anti-D Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-D Immunoglobulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-D Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-D Immunoglobulin Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-D Immunoglobulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-D Immunoglobulin Sales by Country
  2. 10.1.1 South America Anti-D Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-D Immunoglobulin Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-D Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-D Immunoglobulin Market Size by Country
  6. 10.2.1 South America Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-D Immunoglobulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-D Immunoglobulin Sales by Country
  2. 11.1.1 Middle East and Africa Anti-D Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-D Immunoglobulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-D Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-D Immunoglobulin Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-D Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-D Immunoglobulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-D Immunoglobulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-D Immunoglobulin Value Chain Analysis
  2. 12.1.1 Anti-D Immunoglobulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-D Immunoglobulin Production Mode & Process
  7. 12.2 Anti-D Immunoglobulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-D Immunoglobulin Distributors
  10. 12.2.3 Anti-D Immunoglobulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst